Advertisement
Original Communications| Volume 125, ISSUE 1, P23-32, January 1999

Download started.

Ok

Suppressed endothelin-1 production by FK506 and cyclosporin A in ischemia/reperfusion of rat small intestine

      Abstract

      Background: Endothelin-1 (ET-1), a novel vasoconstrictor, possibly plays a role in the mediation of ischemia/reperfusion (I/R) injury. Tacrolimus (FK506) and cyclosporin A (CsA) were reported to maintain tissue microcirculation of the liver subjected to I/R. This study investigated the effects of these immunosuppressants on intestinal I/R in terms of intestinal tissue microcirculation associated with ET-1. Methods and Results: Male S-D rats were pretreated twice with FK506 (0.2 mg/kg), CsA (10 mg/kg) or only saline solution (0.5 mL). The tissue microcirculation in the control was reduced after I/R (29% ± 10%) accompanied by hypotension, increased tissue ET-1 expression (25.0% ± 6.4% to 67.9% ± 5.0% 60 minutes after reperfusion), and increased ET-1 level in the portal blood (3.4 ± 0.9 to 23.6 ± 6.1 pg/mL). FK506 suppressed ET-1 expression (27.3% ± 5.2%, 4.1 ± 2.2 pg/mL), maintained microcirculation (96% ± 16%), and blood pressure, reduced histologic damage, and improved survival. CsA had a similar but weaker effect compared with FK506. An additional experiment was performed with BQ485Na (BQ), an ETA receptor antagonist, to evaluate the genuine role of ET-1. BQ showed almost the same effects as FK506. Conclusions: FK506 and CsA, particularly the former, maintain microcirculation and protect the tissue from I/R injury by suppressing the production and release of ET-1. (Surgery 1999;125:23-32.)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Marston A
        • Bulkley GB
        • Fiddian-Green RG
        • Haglund UH
        Splanchnic ischemia and multiple organ failure.
        Edward Arnold:, London1989
        • Khama SD
        Experimental study of mesenteric occlusion.
        J Pathol Bacteriol. 1959; 77: 575-590
        • Todo S
        • Tzakis AG
        • Abu-Elamagd K
        • Tzakis AG
        • Reyes J
        • Nakamura K
        • et al.
        Intestinal transplantation in composite visceral graft or alone.
        Ann Surg. 1992; 216: 223-233
        • Mehrabi A
        • Kraus TW
        • Klar E
        • Fernandes L
        • Osswald BR
        • Aulmann M
        • et al.
        Analysis of extravascular endothelin levels in UW solution and losing effluent pH porcine liver grafts after cold storage.
        Transplant Proc. 1995; 27: 2613-2615
        • Kawamura E
        • Yamanaka N
        • OkamotoE
        • Tomoda F
        • Furukawa K
        Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury.
        Hepatology. 1995; 21: 1138-1143
        • Stansby G
        • Fuller B
        • Jeremy J
        • Cheetham K
        • Rolles K
        Endothelin release: a facet of reperfusion injury in clinical liver transplantation?.
        Transplantation. 1993; 56: 239-240
        • Whittle BJR
        • Espluguees JV
        Induction of rat gastric damage by the endothelium-derived peptide, endothelin.
        Br J Pharmacol. 1988; 95: 1011-1013
        • Sugiura M
        • Inagami T
        • Kon V
        Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay.
        Biochem Biophys Res Commun. 1989; 161: 1220-1227
        • Dikranian K
        • Tominson A
        • Loesch A
        • Winter R
        • Burnstock G
        Increase in immunoreactivity to endothelin-1 in the mucosal vasoculture and epithelium of the large intestine during chronic hypoxia.
        J Anat. 1994; 185: 609-615
        • Kubes P
        • Hunter J
        • Granger DN
        Effects of cyclosporin A and FK506 on ischemia/reperfusion-induced neutrophil infiltration in the cat.
        Dig Dis Sci. 1991; 36: 1469-1472
        • Suzuki S
        • Toledo-Pereyra LH
        • Rodriguez J
        • Cejalvo D
        Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury.
        Transplantation. 1993; 55: 1265-1272
        • Nishinaka Y
        • Sugiyama S
        • Yokota M
        • Saito H
        • Ozawa T
        Protective effect of FK506 on ischemia/reperfusion-induced myocardial damage in canine heart.
        J Cardiovasc Pharmacol. 1993; 21: 448-454
        • Kawano K
        • Kim YI
        • Goto S
        • Ono M
        • Kobayashi M
        A protective effect of FK506 in ischemically injured rat livers.
        Transplantation. 1991; 52: 143-145
        • Sakr M
        • Zetti G
        • McClain C
        • Gavaler J
        • Nalesnik M
        • Todo S
        • et al.
        The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats.
        Transplantation. 1992; 53: 987-991
        • Wakabayashi H.
        • Karasawa Y
        • Maeba T
        • Tanaka S
        Effect of FK506 and cyclosporine A on hepatic energy status in the rat warm ischemia, as monitored by 31P nuclear magnetic resonance spectroscopy in vivo.
        Transplant Proc. 1992; 24: 1993-1995
        • Kawano K
        • Il Kim Y
        • Kai T
        • Ishii T
        • Tatsuma T
        • Morimoto A
        • et al.
        Evidence that FK506 alleviates ischemia/reperfusion injury to the rat liver: in vivo demonstration for suppression of TNF-α production in response to endotoxemia.
        Eur Surg Res. 1994; 26: 108-115
        • Sharkey J
        • Butcher SP
        Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischemia.
        Nature. 1994; 371: 336-339
        • Kawano K
        • Bowers JL
        • Clouse ME
        Protective effect of FK506 on hepatic injury following cold ischemic preservation and transplantation: influence on hepatic microcirculation.
        Transplant Proc. 1995; 27: 362-363
        • Yamanoi A
        • Nagasue N
        • Kohno H
        • Chang YC
        • Hayashi T
        • Nakamura T
        Attenuation of ischemia-reperfusion injury of the liver in dogs by cyclosporin A comparative study with allopurinol and methylprednisolone.
        Transplantation. 1991; 52: 27-30
        • Leszczynski D
        • Zhao Y
        • Yeagley TJ
        • Fögh ML
        Direct and endothelial cell-mediated effect of cyclosporin A on the proliferation of rat smooth muscle cells in vitro.
        Am J Pathol. 1993; 142: 149-155
        • Roullet JB
        • Xue H
        • McCarron DA
        • Holcomb S
        • Bennett WM
        Vascular mechanisms of cyclosporin-induced hypertension in the rat.
        J Clin Invest. 1994; 93: 2244-2250
        • Takeda M
        • Iwasaki S
        • Hellings SE
        • Yoshida H
        • Homma T
        • Kon V
        Divergent expression of ETA and ETB receptors in response to cyclosporin in mesangial cells.
        Am J Pathol. 1994; 144: 473-479
        • Benigni A
        • Morigi M
        • Perico N
        • Zoja C
        • Amuchastegui CS
        • Piccinelli A
        • et al.
        The acute effect of FK506 and cyclosporin on endothelial cell function and renal vascular resistance.
        Transplantation. 1992; 554: 775-780
        • Park PO
        • Wallander J
        • Trufveson G
        • Haglund U
        Cold ischemic and reperfusion injury in a model of small bowel transplantation in the rat.
        Eur Surg Res. 1991; 23: 1-8
        • Zikria BA
        • Oz MO
        • Carlson RW
        Reperfusion injuries and clinical capillary leak syndrome.
        Futura, New York1994
        • Firth JD
        • Ratcliffe PJ
        Organ distribution of three rat endothelin messenger RNAs and effects of ischemia on renal gene expression.
        J Clin Invest. 1992; 90: 1023-1031
        • Yanagisawa M.
        • Kurihara H
        • Kimura S
        • Tomobe Y
        • Kobayashi M
        • Mitsui Y
        • et al.
        A novel potent vasoconstrictor peptide produced by vascular endothelial cells.
        Nature. 1988; 332: 411-415
        • Takahashi K
        • Jones PM
        • Kanse SM
        • Lam H
        • Spokes RA
        • Ghatei MA
        • et al.
        Endothelin in the gastrointestinal tract.
        Gastroenterology. 1990; 99: 1660-1667
        • Inagaki H
        • Bishop AE
        • Escrig C
        • Wharton J
        • Allen-Mersh TG
        • Polak JM
        Localization of endothelin-like immunoreactivity and endothelin binding sites in human colon.
        Gastroenterology. 1991; 101: 47-54
        • Furuya S
        • Naruse S
        • Nakayama T
        • Nokihara K
        125I-Endothelin binds to fibroblasts beneath the epithelium of rat small intestine.
        J Electron Microsc. 1990; 39: 264-268
        • Shibouta Y
        • Suzuki N
        • Shino A
        • Matsumoto H
        • Terashita Z
        • Kondo K
        • et al.
        Pathophysiological role of endothelin in acute renal failure.
        Life Sci. 1990; 46: 1611-1618
        • Kraus TW
        • Mehrabi A
        • Klar E
        • Osswald BR
        • Fernandes L
        • Aulmann M
        Endothelin concentration in porcine hepatic tissue during ischemia and reperfusion.
        Transplant Proc. 1995; 27: 2732-2752
        • Ross R
        The pathogenesis of atherosclerosis: a perspective for the 1990s.
        Nature. 1993; 362: 801-809
        • Murch SH
        • Braegger CP
        • Sessa WC
        • MacDonald TT
        High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis.
        Lancet. 1992; 339: 381-385
        • Mino N
        • Kobayashi M
        • Nakajima A
        • Amano H
        • Shimamoto K
        • Ishikawa K
        • et al.
        Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats.
        Eur J Pharmacol. 1992; 221: 77-83
        • Grover GJ
        • Dzwonczyk S
        • Parham CS
        The endothelin-1 receptor antagonist BQ123 reduces infarct size in canine model of coronary occlusion and reperfusion.
        Cardiovasc Res. 1993; 27: 1613-1618
        • Itoh S
        • Sasaki T
        • Ide K
        • Ishikawa K
        • Nishikibe M
        • Yano M
        A novel endothelin ETA receptor antagonist, BQ485, and its preventive effect on experimental cerebral vasospasm in dogs.
        Biochem Biophys Res Commun. 1993; 195: 969-975
        • Yanagisawa M
        • Inoue A
        • Takuwa Y
        • Mitsui Y
        • Kobayashi M
        • Masaki T
        The human preproendothelin-1 gene: possible regulation by endothelin phosphoinositide turnover signaling.
        J Cardiovasc Pharmacol. 1989; 13: S13-S17
        • Imai T
        • Hirata Y
        • Emori T
        • Marumo F
        Heparin has an inhibitory effect on endothelin-1 synthesis and release by endothelial cells.
        Hypertension. 1993; 21: 353-358